Fukushima S - Search Results

1

miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma.

Nguyen MT, Lin CH, Liu SM, Miyashita A, Ihn H, Lin H, Ng CH, Tsai JC, Chen MH, Tsai MS, Lin IY, Liu SC, Li LY, Fukushima S, Lu J, Ma N. Nguyen MT, et al. Among authors: fukushima s. Neoplasia. 2020 Dec;22(12):789-799. doi: 10.1016/j.neo.2020.10.009. Epub 2020 Nov 2. Neoplasia. 2020. PMID: 33142243 Free PMC article.

2

Differential expression of heat shock protein 105 in melanoma and melanocytic naevi.

Muchemwa FC, Nakatsura T, Fukushima S, Nishimura Y, Kageshita T, Ihn H. Muchemwa FC, et al. Among authors: fukushima s. Melanoma Res. 2008 Jun;18(3):166-71. doi: 10.1097/CMR.0b013e3282fe9a16. Melanoma Res. 2008. PMID: 18477890

3

Fixed food eruption caused by cashew nut.

Fukushima S, Kidou M, Ihn H. Fukushima S, et al. Allergol Int. 2008 Sep;57(3):285-7. doi: 10.2332/allergolint.C-07-58. Epub 2008 Jul 1. Allergol Int. 2008. PMID: 18566551 Free article.

4

Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy.

Fukushima S, Egawa K, Nishi H, Wakasugi S, Ishii N, Hashimoto T, Yancey KB, Ihn H. Fukushima S, et al. Acta Derm Venereol. 2008;88(5):484-7. doi: 10.2340/00015555-0506. Acta Derm Venereol. 2008. PMID: 18779887 Free article.

5

Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.

Fukushima S, Hirata S, Motomura Y, Fukuma D, Matsunaga Y, Ikuta Y, Ikeda T, Kageshita T, Ihn H, Nishimura Y, Senju S. Fukushima S, et al. J Immunother. 2009 Apr;32(3):219-31. doi: 10.1097/CJI.0b013e318194b63b. J Immunother. 2009. PMID: 19242378

6

Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways.

Makino T, Jinnin M, Muchemwa FC, Fukushima S, Kogushi-Nishi H, Moriya C, Igata T, Fujisawa A, Johno T, Ihn H. Makino T, et al. Among authors: fukushima s. Br J Dermatol. 2010 Apr;162(4):717-23. doi: 10.1111/j.1365-2133.2009.09581.x. Epub 2009 Dec 1. Br J Dermatol. 2010. PMID: 19995368

7

Transglutaminase1 preferred substrate peptide K5 is an efficient tool in diagnosis of lamellar ichthyosis.

Akiyama M, Sakai K, Yanagi T, Fukushima S, Ihn H, Hitomi K, Shimizu H. Akiyama M, et al. Among authors: fukushima s. Am J Pathol. 2010 Apr;176(4):1592-9. doi: 10.2353/ajpath.2010.090597. Epub 2010 Feb 18. Am J Pathol. 2010. PMID: 20167857 Free PMC article.

8

Impaired lymphangiogenesis due to excess vascular endothelial growth factor-D/Flt-4 signalling in the skin of patients with systemic sclerosis.

Honda N, Jinnin M, Kajihara I, Makino T, Fukushima S, Ihn H. Honda N, et al. Among authors: fukushima s. Br J Dermatol. 2010 Oct;163(4):776-80. doi: 10.1111/j.1365-2133.2010.09853.x. Br J Dermatol. 2010. PMID: 20491763

9

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis.

Higashi-Kuwata N, Jinnin M, Makino T, Fukushima S, Inoue Y, Muchemwa FC, Yonemura Y, Komohara Y, Takeya M, Mitsuya H, Ihn H. Higashi-Kuwata N, et al. Among authors: fukushima s. Arthritis Res Ther. 2010;12(4):R128. doi: 10.1186/ar3066. Epub 2010 Jul 5. Arthritis Res Ther. 2010. PMID: 20602758 Free PMC article.

10

Serum levels of soluble CD163 in patients with systemic sclerosis.

Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Inoue Y, Ihn H. Nakayama W, et al. Among authors: fukushima s. Rheumatol Int. 2012 Feb;32(2):403-7. doi: 10.1007/s00296-010-1691-z. Epub 2010 Dec 1. Rheumatol Int. 2012. PMID: 21120485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,132 results

Search Page